{
    "2020-08-19": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：如何看待近期医药的回调？",
                "features": {
                    "keywords": [
                        "医药",
                        "回调"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物-中国疫苗行业纵观(一)：脚踏实地 仰望星空",
                "features": {
                    "keywords": [
                        "疫苗",
                        "行业",
                        "纵观"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫苗板块整体下挫近2%，智飞生物、复星医药、康泰生物跌幅居前",
                "features": {
                    "keywords": [
                        "疫苗",
                        "板块",
                        "下挫",
                        "智飞生物",
                        "复星医药",
                        "康泰生物"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业投资周报：保持定力紧抓优势赛道龙头 疫情股侧重长期影响和疫苗临床进展",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "投资",
                        "疫情",
                        "疫苗",
                        "临床进展"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}